Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Renaissance Insurance reported for 9 months of 2023

11/17/23 RENI

MKB reported for 9 months of 2023 by IFRS

11/17/23 CBOM

TCS Group will enter the advertising market

11/17/23 T

TRK reported for 9 months of 2023 by IFRS

11/17/23 TORS

Board of Directors of Sovcomflot recommended dividends

11/16/23 FLOT

Shareholders are planning to change NLMK's president

11/16/23 NLMK

Whoosh tested an electric scooter with a computer vision module

11/16/23 WUSH

Walmart reported for 9 months of fiscal year 2024

11/16/23 WMT

Macy's reported for 9 months of 2023

11/16/23 M

MTS reported for 9 months of 2023 by IFRS

11/16/23 MTSS